|
QuarzanDrug - Quarzan The trade name of the product as shown on the labeling.
Dosage -
CAPSULE; ORAL
Active Ingredient(s) -
Clidinium Bromide
Strength -
2.5MG
Applicant -
ROCHE
New Drug Application (NDA) Number -
010355
Product Number -
001
Therapeutic Equivalence (TE) Code -
Approval Date -
Approved Prior to Jan 1, 1982
Reference Listed Drug (RLD) -
No
Type -
DISCN
Applicant Full Name -
Hoffmann La Roche Inc
Quarzan
Tavist-1 1.34mg Tablet; Oral
Tavist-d 1.34mg;75mg Tablet, Extended Release; Oral Tavist-d 1.34mg;75mg Tablet, Extended Release; Oral Tavist-d Eq 1mg Base;75mg Tablet, Extended Release; Oral Quarzan 2.5mg Capsule; Oral Clemastine Fumarate 1.34mg Tablet; Oral Clemastine Fumarate 2.68mg Tablet; Oral Tavist 2.68mg Tablet; Oral Tavist-1 1.34mg Tablet; Oral Tavist-1 1.34mg Tablet; Oral NewDrugInformation |